 |
 |

Glaucoma Medication AdherenceRoom for Improvement in Both Performance and Measurement
Kelly W. Muir, MD;
Paul P. Lee, MD, JD
Arch Ophthalmol. 2011;129(2):243-245. doi:10.1001/archophthalmol.2010.351
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Glaucoma is the leading cause of irreversible blindness worldwide1-2 and the number of Americans with glaucoma is expected to increase by 50% in the next 15 years.3 Multiple clinical trials have shown that with effective medical treatment, much (but not all) vision loss can be prevented.4-6 Whether measured by pharmacy data,7 self-report,8-9 or medication monitor,10 adherence to glaucoma medication is often poor. Investigators studying medication adherence have identified multiple factors related to poor adherence, including more frequent11 and complex12 dosing and situational factors, such as competing activities12 and forgetfulness,8 as well as patient-centered factors, such as poor disease knowledge,13 poor health literacy,14 and a passive learning style.13 This information is important because the identification of barriers to adherence facilitates a better understanding of the problems and possible interventions to reduce these barriers. However, to critique the success or failure of such . . . [Full Text of this Article]ADHERENCE, PERSISTENCE, AND COMPLIANCE
COMPONENTS OF MEDICATION ADHERENCE
METHODS OF MEASURING MEDICATION ADHERENCE
SIGNIFICANCE
AUTHOR INFORMATION
Author Affiliations: Duke University Eye Center, Durham, North Carolina.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
|